GB1173160A - Pharmaceutical Compositions for the Treatment of Diabetes - Google Patents
Pharmaceutical Compositions for the Treatment of DiabetesInfo
- Publication number
- GB1173160A GB1173160A GB54894/66A GB5489466A GB1173160A GB 1173160 A GB1173160 A GB 1173160A GB 54894/66 A GB54894/66 A GB 54894/66A GB 5489466 A GB5489466 A GB 5489466A GB 1173160 A GB1173160 A GB 1173160A
- Authority
- GB
- United Kingdom
- Prior art keywords
- represent
- dec
- salts
- carbon atoms
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 2
- KZTWONRVIPPDKH-UHFFFAOYSA-N 2-(piperidin-1-yl)ethanol Chemical class OCCN1CCCCC1 KZTWONRVIPPDKH-UHFFFAOYSA-N 0.000 abstract 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 abstract 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 abstract 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000004922 lacquer Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1709565 | 1965-12-09 | ||
| CH1709665A CH454874A (de) | 1965-12-09 | 1965-12-09 | Verfahren zur Herstellung von neuen N' -substituierten N-Arylsulfonylharnstoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1173160A true GB1173160A (en) | 1969-12-03 |
Family
ID=25719008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB54894/66A Expired GB1173160A (en) | 1965-12-09 | 1966-12-08 | Pharmaceutical Compositions for the Treatment of Diabetes |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE690894A (enrdf_load_stackoverflow) |
| CH (1) | CH454874A (enrdf_load_stackoverflow) |
| DE (1) | DE1695001A1 (enrdf_load_stackoverflow) |
| FR (1) | FR6066M (enrdf_load_stackoverflow) |
| GB (1) | GB1173160A (enrdf_load_stackoverflow) |
| NL (1) | NL6617269A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8314080B2 (en) | 2010-04-06 | 2012-11-20 | Kuwait University | Method of treating type I diabetes |
-
1965
- 1965-12-09 CH CH1709665A patent/CH454874A/de unknown
-
1966
- 1966-12-08 DE DE19661695001 patent/DE1695001A1/de active Pending
- 1966-12-08 NL NL6617269A patent/NL6617269A/xx unknown
- 1966-12-08 GB GB54894/66A patent/GB1173160A/en not_active Expired
- 1966-12-08 BE BE690894D patent/BE690894A/xx unknown
- 1966-12-08 FR FR86641A patent/FR6066M/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8314080B2 (en) | 2010-04-06 | 2012-11-20 | Kuwait University | Method of treating type I diabetes |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1695001A1 (de) | 1971-05-06 |
| BE690894A (enrdf_load_stackoverflow) | 1967-06-08 |
| NL6617269A (enrdf_load_stackoverflow) | 1967-06-12 |
| CH454874A (de) | 1968-04-30 |
| FR6066M (enrdf_load_stackoverflow) | 1968-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES488656A1 (es) | Procedimiento para la preparacion de derivados de acidos aziridin-2-carboxilicos substituidos en n | |
| ATE59033T1 (de) | N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
| ES345981A1 (es) | Procedimiento para la obtencion de alimentos para aves. | |
| GB1295228A (enrdf_load_stackoverflow) | ||
| GB1173160A (en) | Pharmaceutical Compositions for the Treatment of Diabetes | |
| GB989013A (en) | New guanidines and process for their manufacture | |
| GB1142066A (en) | New diphenyl-ureas and process for preparing them | |
| GB1186863A (en) | Salts of 6-Phosphogluconic Acid and Pharmaceutical Compositions containing 6-Phosphogluconic Acid or Salts thereof | |
| GB1322370A (en) | Hydroxycrotonic acid derivatives their preparation and compositions containing them and intermediates for the preparation of the same | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1459372A (en) | 4-3-amino-2-hydroxy-propyloxy-benzimidazole derivatives | |
| GB1356117A (en) | 1-3-cyano-3,3-diphenylpropyl-4-phenylpiperidine-4-carboxylic acid derivatives | |
| GB1207930A (en) | Azacycloaliphatic compounds, process for their manufacture and compositions containing them | |
| GB972082A (en) | Dihydrodibenzazepinones | |
| CA2210533A1 (en) | Imidazole derivatives, their preparation and their use as s-adenosylmethionine decarboxylase (=samdc) inhibitors | |
| GB1250353A (enrdf_load_stackoverflow) | ||
| GB1153792A (en) | Pharmaceutical Compositions | |
| GB1468079A (en) | Ethanolamine derivatives | |
| GB1305725A (enrdf_load_stackoverflow) | ||
| GB1466924A (en) | Indazole derivatives | |
| GB1253521A (en) | Novel xanthen and thiaxanthen derivatives and the preparation thereof | |
| GB1225412A (enrdf_load_stackoverflow) | ||
| GB1284582A (en) | Substituted piperazinopyrimidinones | |
| GB1390091A (en) | 4-4-biphenylyl-butyric acid derivatives | |
| GB927288A (en) | 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |